NEXENTIS TECHNOLOGIES INC. Assets, Fair Value Disclosure
NEXENTIS TECHNOLOGIES INC. (NXTS) had Assets, Fair Value Disclosure of $4.69 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2026-08-13
- 2026-06-30: Assets, Fair Value Disclosure $4.69M.
- 2026-03-31: Assets, Fair Value Disclosure $5.12M.
- 2025-12-31: Assets, Fair Value Disclosure $3.38M.
- 2025-09-30: Assets, Fair Value Disclosure $3.20M.
| Period end | Assets, Fair Value Disclosure | Assets, Fair Value Disclosure as first filed |
|---|---|---|
| 2026-06-30 | $4.69M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $5.12M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $3.38M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $3.20M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $3.06M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $3.09M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $2.30M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $2.23M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $1.93M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $1.74M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $1.66M 10-K · filed 2025-03-31 | $1.66M 10-K · filed 2024-04-01 |
| 2023-09-30 | $2.28M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $2.05M 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |